Dogwood Therapeutics, Inc. - Common Stock (DWTX)
2.4800
-0.1500 (-5.70%)
NASDAQ· Last Trade: Sep 2nd, 6:10 PM EDT
Dogwood Therapeutics (NASDAQ:DWTX) said its Phase 2b study of Halneuron, an investigational treatment for chemotherapy-induced neuropathic pain, has enrolled more than 230 patients and is expected to report top-line data later this fall.
During a virtual key opinion leader event, Chief Executive Of
Via MarketBeat · September 1, 2026
Dogwood Therapeutics (NASDAQ:DWTX) Beats EPS Estimates in Q1 2026, Phase 2b Trial on Trackchartmill.com
Via Chartmill · May 14, 2026
The company said that Halneuron demonstrated separation from placebo treated patients in terms of pain improvement but did not detail the scale of the said improvement.
Via Stocktwits · December 22, 2025
Dogwood Therapeutics reports a Q3 2025 earnings miss but highlights key progress for its Halneuron® Phase 2b trial, with interim analysis on track for late 2025.
Via Chartmill · November 6, 2025
Before the US market kicks off on Thursday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers.
Via Chartmill · October 2, 2025
Via Benzinga · October 2, 2025
Via Benzinga · October 2, 2025
Gainers cbdMD (AMEX:YCBD) shares rose 116.3% to $1.35 during Monday's regular session. The company's market cap stands at $5.5 million. Zura Bio (NASDAQ: ZURA) stock moved upwards by 42.94% to $3.44. The company's market cap stands at $156.6 million.
Via Benzinga · September 29, 2025
In return for the license, Sepin Pharma and its designated affiliates will get 7.31% of Dogwood’s common stock, on a fully diluted basis.
Via Stocktwits · September 29, 2025
Gainers Dogwood Therapeutics (NASDAQ: DWTX) stock moved upwards by 80.1% to $9.94 during Monday's pre-market session. The market value of their outstanding shares is at $10.5 million.
Via Benzinga · September 29, 2025
Keep an eye on the top gainers and losers in Monday's session, as they reflect the most notable price movements.
Via Chartmill · April 21, 2025
In today's session, there are stocks attracting attention with their unusual volume. Let's take a closer look.
Via Chartmill · April 21, 2025
Looking for insights into the US markets in the middle of the day on Monday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
Via Chartmill · April 21, 2025
The market is filled with gapping stocks in Monday's session. Let's discover which stocks are showing gap-ups and gap-downs.
Via Chartmill · April 21, 2025
Via Benzinga · April 21, 2025
Here are the top movers in Thursday's session, showcasing the stocks with significant price changes.
Via Chartmill · April 17, 2025
Via Benzinga · April 17, 2025
Discover the top movers in Tuesday's after-hours session and stay informed about the post-market dynamics.
Via Chartmill · April 15, 2025
Via Benzinga · April 15, 2025
Here are the top movers in Tuesday's session, showcasing the stocks with significant price changes.
Via Chartmill · April 15, 2025
Curious about what's happening in today's session? Check out the latest stock movements and price changes.
Via Chartmill · April 15, 2025
Via Benzinga · April 15, 2025
Via Benzinga · April 9, 2025
